000 01344 a2200325 4500
005 20250514014902.0
264 0 _c20011204
008 200112s 0 0 eng d
022 _a1523-6838
024 7 _a10.1053/ajkd.2001.28110
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSprague, S M
245 0 0 _aSuppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol.
_h[electronic resource]
260 _bAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_cNov 2001
300 _aS51-6 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aCalcitriol
_xtherapeutic use
650 0 4 _aCalcium
_xblood
650 0 4 _aErgocalciferols
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aParathyroid Hormone
_xblood
650 0 4 _aPhosphorus
_xblood
650 0 4 _aRenal Dialysis
700 1 _aLerma, E
700 1 _aMcCormmick, D
700 1 _aAbraham, M
700 1 _aBatlle, D
773 0 _tAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
_gvol. 38
_gno. 5 Suppl 5
_gp. S51-6
856 4 0 _uhttps://doi.org/10.1053/ajkd.2001.28110
_zAvailable from publisher's website
999 _c11606024
_d11606024